| Literature DB >> 31619602 |
Totaro Takeuchi1, Eishi Kasahara2.
Abstract
This study consisted of 29 patients with idiopathic normal pressure hydrocephalus (iNPH) who underwent lumbosubarachnoid-lumboepidural (L-L) shunting under local anesthesia in accordance with our surgical indications of L-L shunting. (1) CSF absorption within the lumbar epidural space and shunt clearance were confirmed in all patients after operation. (2) Shunt responders (R) were 25 of 29 cases (86.2%) 3 months after surgery. Among the R, symptom exacerbation was confirmed in three patients (12%) within the follow-up period (mean, 25.1 months). In each of these patients, shunt function were maintained and remained unchanged even with pressure resetting, the cause being an intracranial/extracranial disease other than iNPH. (3) The initial pressure setting for this method was 8 cmH2O, with gradual change to higher pressures, such that the setting for Patient 11 and thereafter became 20 cmH2O. (4) As postsurgical complications, subcutaneous cerebral spinal fluid collection (SCC) was confirmed in five patients (17.2%). In high-pressure resetting and follow-up observation, SCC was not observed in all patients. Epidural catheter displacement was confirmed in three patients (10.3%). No recurrence was noted after the secure fixation of the catheter at the fascia insertion portion and 2 days' postsurgical bed rest. Hence, L-L shunting is an effective shunt therapy for iNPH.Entities:
Keywords: idiopathic; lumbosubarachnoid-lumboepidural (L-L) shunting; normal pressure hydrocephalus
Mesh:
Year: 2019 PMID: 31619602 PMCID: PMC6923158 DOI: 10.2176/nmc.oa.2019-0151
Source DB: PubMed Journal: Neurol Med Chir (Tokyo) ISSN: 0470-8105 Impact factor: 1.742
Objective cases (N = 29)
| Age | Sex | General complication | Set-up pressure (cmH2O) | Postop. complication | JNPHGS-R | Shunt efficacy | |||
|---|---|---|---|---|---|---|---|---|---|
| SCC | Deviation of catheter | Preop. | Postop. 3 months | ||||||
| 1 | 77 | M | HD, Cancer | 8 | G2 D3 U2 | G1 D3 U0 | R | ||
| 2 | 79 | M | HD, DM, HT | 8 | G4 D4 U3 | G2 D3 U1 | R | ||
| 3 | 80 | F | COPD, DM | 8 → 6 → 4 | G3 D2 U1 | G3 D2 U1 | NR | ||
| 4 | 83 | M | HD, HT | 8 | G3 D1 U2 | G1 D1 U0 | R | ||
| 5 | 85 | M | LD, RD | 8 → 6 → 10 → 12 | + | + | G2 D2 U2 | G1 D2 U1 | R |
| 6 | 86 | M | COPD, HD | 8 → 4 → 2 | G4 D3 U1 | G4 D3 U1 | NR | ||
| 7 | 87 | F | Cancer | 8 → 10 → 12 | + | G2 D1 U1 | G2 D1 U0 | R | |
| 8 | 66 | F | Abdominal cyst | 12 | G3 D2 U3 | G2 D1 U1 | R | ||
| 9 | 73 | M | HD | 12 → 15 → 20 | + | G2 D2 U3 | G1 D2 U0 | R | |
| 10 | 87 | M | Colon cancer | 15 → 20 | + | G3 D3 U3 | G2 D2 U1 | R | |
| 11 | 98 | M | HD, RD | 20 | G2 D2 U3 | G1 D2 U1 | R | ||
| 12 | 96 | F | COPD, HT | 20 | G3 D2 U1 | G2 D1 U0 | R | ||
| 13 | 76 | M | RD (hemodialysis) | 20 | G3 D3 U2 | G2 D3 U1 | R | ||
| 14 | 86 | M | RD (hemodialysis) | 20 → 15 | G4 D3 U4 | G3 D3 U2 | R | ||
| 15 | 86 | F | HD, DM, HT | 20 → 15 → 10 → 8 | G3 D2 U2 | G3 D2 U2 | NR | ||
| 16 | 81 | M | Colon disease | 20 | G2 D3 U2 | G1 D3 U1 | R | ||
| 17 | 86 | F | HD, cancer | 20 → 15 → 12 | G2 D3 U3 | G1 D3 U1 | R | ||
| 18 | 84 | M | HD | 20 | G3 D2 U2 | G1 D1 U0 | R | ||
| 19 | 81 | F | HLD | 20 → 18 → 15 | + | G2 D2 U3 | G1 D2 U1 | R | |
| 20 | 78 | M | HT | 20 | G3 D3 U4 | G2 D2 U1 | R | ||
| 21 | 77 | M | DM | 20 | G2 D3 U1 | G1 D3 U0 | R | ||
| 22 | 80 | M | Abdominal disease | 20 → 15 | G4 D3 U3 | G3 D3 U1 | R | ||
| 23 | 84 | M | COPD | 20 | G4 D4 U4 | G3 D3 U2 | R | ||
| 24 | 70 | F | HLD, HT | 20 | G2 D2 U2 | G1 D2 U1 | R | ||
| 25 | 89 | M | DM | 20 | G3 D3 U2 | G2 D3 U1 | R | ||
| 26 | 69 | M | Cancer | 20 → 15 | G3 D2 U4 | G3 D2 U1 | R | ||
| 27 | 73 | M | HD | 20 | G3 D2 U2 | G1 D2 U0 | R | ||
| 28 | 75 | F | HT | 20 → 15 → 10 | + | G3 D3 U2 | G3 D3 U2 | NR | |
| 29 | 71 | F | HD | 20 → 15 → 10 → 5 | + | G4 D3 U3 | G2 D2 U1 | R | |
Symptom worsened during the follow-up period. COPD: chronic obstructive pulmonary disease, D: dementia, DM: diabetes mellitus, F: female, G: gait disturbance, HD: heart disease, HTN: hypertension, HLD: hyperlipidosis, JNPHGS-R: Japanese Normal Pressure Hydrocephalus Grading Scale-Revised,[3)] M: male, NR: shunt nonresponder, R: shunt responder, RD: renal disease, SCC: subcutaneous cerebrospinal fluid collection, U: urinary incontinence.
Surgical indications of Lumbosubarachnoid-Lumboepidural (L-L) shunting
|
Probable iNPH Advanced age (almost more than 80 years.)
Condition of patients
The cases who are considered to be at high risk from general or lumbar anesthesia to the presence of serious systemic complications (diseases of lung, heart, liver, kidney etc,) and/or
The cases where it is not possible to insert the catheter into abdominal cavity because of the existence of severe abdominal disease (abdominal cyst, colon disease, abdominal operation in past disease etc.)
No operation of spinal canal stenosis in past history. The cases who are requested L-L shunting by patients and/or family. |
iNPH: idiopathic normal pressure hydrocephalus.
Fig. 1Lumbosubarachnoid-lumboepidural (L-L) shunting on three-dimensional computed tomography image (Patient 7: left, anterior-posterior view; right, lateral view).
Fig. 2Lumbar epidural space cerebrospinal fluid absorption test on sagittal computed tomography image (Patient 16: arrows, contrast media in lumbar epidural space; just after, just after injection; after 48 h, 48 h after injection).
Fig. 3Pump clearance test on axial computed tomography image (Patient 24: arrows, contrast media in pump; just after, just after injection; after 12 h, 12 h after injection; after 24 h, 24 h after injection).